What is the most likely diagnosis for a patient with primary amenorrhea, normal adult-size breasts, coarse pubic and axillary hair, and hyperandrogenism (elevated testosterone level)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Likely Diagnosis: Complete Androgen Insensitivity Syndrome (CAIS)

The most likely diagnosis is Complete Androgen Insensitivity Syndrome (CAIS) - Option B. This patient presents with the classic triad of primary amenorrhea, normal breast development, and markedly elevated testosterone (13.86 nmol/L, nearly 5 times the upper limit of normal), but with coarse pubic and axillary hair, which requires careful interpretation.

Clinical Reasoning

Why CAIS is Most Likely

  • Primary amenorrhea with normal breast development indicates the presence of estrogen but absence of a functional uterus or endometrial response 1
  • Markedly elevated testosterone (13.86 nmol/L vs normal 0.7-2.8 nmol/L) in the setting of primary amenorrhea points to either androgen insensitivity or an androgen-producing condition 1
  • In CAIS, patients have 46,XY karyotype with testes that produce testosterone, but complete androgen receptor dysfunction prevents virilization while allowing aromatization of testosterone to estrogen, resulting in normal female breast development 1

The Pubic/Axillary Hair Paradox

  • This is the key clinical nuance: Classic teaching states CAIS patients have absent or sparse pubic/axillary hair due to complete androgen insensitivity 1
  • However, the presence of "coarse" hair in this case may represent:
    • Partial rather than complete insensitivity (though this would typically show some virilization)
    • Adrenal androgen contribution (DHEAS-mediated hair growth can occur independently of testosterone receptor function) 2
    • Individual variation in the clinical presentation 1

Why Other Options Are Less Likely

Option A: Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome

  • MRKH presents with primary amenorrhea and normal breast development, BUT testosterone levels are normal female range (0.7-2.8 nmol/L), not elevated 1
  • The markedly elevated testosterone (13.86 nmol/L) essentially excludes this diagnosis 1

Option C: Asherman's Syndrome

  • Asherman's syndrome causes secondary amenorrhea (acquired intrauterine adhesions), not primary amenorrhea 1
  • Requires prior uterine instrumentation or infection 1
  • This diagnosis is incompatible with the clinical presentation 1

Option D: Turner Syndrome

  • Turner syndrome (45,XO) presents with primary amenorrhea but with absent or poor breast development due to ovarian dysgenesis and estrogen deficiency 1
  • Testosterone levels would be low-normal, not markedly elevated 1
  • The normal breast development excludes this diagnosis 1

Diagnostic Approach

Essential Next Steps

  • Karyotype analysis to confirm 46,XY in suspected CAIS 1
  • Pelvic ultrasound or MRI to identify absent uterus and presence of intra-abdominal or inguinal testes 1
  • Repeat testosterone measurement using LC-MS/MS methodology in the morning for confirmation 2, 1
  • LH and FSH levels (typically elevated in CAIS due to lack of negative feedback) 1

Critical Pitfall to Avoid

  • Do not assume all CAIS patients have completely absent body hair - there is phenotypic variation, and adrenal androgens can contribute to hair growth independently of testosterone receptor function 2, 1
  • The presence of pubic/axillary hair should not exclude CAIS when other features (primary amenorrhea, normal breasts, markedly elevated testosterone) strongly suggest this diagnosis 1

Management Implications

  • Gonadectomy is recommended after completion of puberty due to 25-50% risk of malignant transformation of undescended testes 1
  • Psychological support and counseling regarding diagnosis, fertility implications, and gender identity 1
  • Hormone replacement therapy with estrogen after gonadectomy to maintain bone health and prevent menopausal symptoms 1

References

Guideline

Hyperandrogenism Diagnosis and Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.